Valion Bio, Inc.
VBIO
#11191
Rank
โ‚น0.22 B
Marketcap
โ‚น116.75
Share price
6.03%
Change (1 day)
N/A
Change (1 year)

Revenue for Valion Bio, Inc. (VBIO)

Revenue in 2026 (TTM): -โ‚น14.14 Million

According to Valion Bio, Inc.'s latest financial reports the company's current revenue (TTM ) is -โ‚น14.81 Million. In 2025 the company made a revenue of -โ‚น14.01 Million a decrease over the revenue in the year 2024 that were of โ‚น66.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Valion Bio, Inc. from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) -โ‚น14.14 Million0.97%
2025 -โ‚น14.01 Million-120.93%
2024 โ‚น66.91 M-31.65%
2023 โ‚น97.9 M-35.74%
2022 โ‚น0.15 B65.86%
2021 โ‚น91.84 M